Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure
Sponsor: National Institute of Hygiene and Epidemiology, Vietnam
Summary
A Study to evaluate if the 3 dose extended schedule (0-6-18 months) for the HPV vaccine Gardasil-9 provide similar immune responses and short term protection against HPV infection compared to the regular 3 dose schedule (0-2-6 months) in high risk women in Vietnam
Official title: A Non-inferiority Study Comparing the Immunogenicity of a Standard or an Extended Three-dose Nonavalent Human Papillomavirus Vaccine Schedule Between High-risk Women Aged 18-26 Years and Age-matched Women in the General Population
Key Details
Gender
FEMALE
Age Range
18 Years - 26 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2024-12-14
Completion Date
2027-12-31
Last Updated
2024-11-08
Healthy Volunteers
Yes
Interventions
Human papillomavirus 9-valent vaccine, Recombinant
HPV vaccine manufactured by MSD consisted of 9HPV types: 6,11,16,18,31,33, 45, 52,58
Locations (3)
Murdoch Children Research Institute
Parkville, Victoria, Australia
Center for Supporting Community Development Initiatives SCDI-Vietnam
Haiphong, Vietnam
Hai Phong Center for Disease Control
Haiphong, Vietnam